Registrera dig | Logga in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuhs rct [447 articles]

Senaste hänvisningarna i jyuhs bibliotek insorterade under taggen rct. You can also see everyone's rct.
  • How to spot bias and other potential problems in randomised controlled trials
    J Neurol Neurosurg Psychiatry, Vol. 75, No. 2. (1 February 2004), pp. 181-187.
    by SC Lewis, CP Warlow
    posted to rct bias by jyuh on 2008-09-02 09:22:20 as **
  • Interpreting Results of Clinical Trials: A Conceptual Framework
    Clin J Am Soc Nephrol, Vol. 3, No. 5. (1 September 2008), pp. 1246-1252.
    by Ajay K Singh, Ken Kelley, Rajiv Agarwal
    posted to rct by jyuh on 2008-09-02 09:19:30 as **
  • The Hawthorne Effect: a randomised, controlled trial
    BMC Medical Research Methodology, Vol. 7 (03 July 2007), 30.
    by Rob Mccarney, James Warner, Steve Iliffe, Robbert van Haselen, Mark Griffin, Peter Fisher
    posted to bias rct by jyuh on 2008-08-26 09:25:17 as ** along with 1 person rabloomfield
  • Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
    The Lancet, Vol. 371, No. 9627., pp. 1854-1860.
    by Hein JEM Janssens, Matthijs Janssen, Eloy H van de Lisdonk, Piet LCM van Riel, Chris van Weel
    posted to gout rct steroid by jyuh on 2008-08-19 10:17:01 as **
  • Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (22 July 2008)
    by Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara, Naofumi Ikeda, Junko Shoda, Tsuneo Takenaka, Tsutomu Inoue, Ryuichiro Araki
    posted to arb cv hd rct by jyuh on 2008-08-06 09:19:29 as **
  • Angiotensin Receptor Blockers: Current Status and Future Prospects
    The American Journal of Medicine, Vol. 121, No. 8. (August 2008), pp. 656-663.
    by Ram
    posted to arb rct by jyuh on 2008-08-06 08:42:27 as **
  • Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
    The New England journal of medicine, Vol. 356, No. 16. (19 April 2007), pp. 1620-1630.
    by JJ Kastelein, SI van Leuven, L Burgess, GW Evans, JA Kuivenhoven, PJ Barter, JH Revkin, DE Grobbee, WA Riley, CL Shear, WT Duggan, ML Bots,
    posted to cad hdl rct surrogate by jyuh on 2008-08-06 07:37:54 as **
  • Disordered Mineral Metabolism in Hemodialysis Patients: An Analysis of Cumulative Effects in the Hemodialysis (HEMO) Study.
    American journal of kidney diseases : the official journal of the National Kidney Foundation (25 July 2008)
    by Ron Wald, Mark J J Sarnak, Hocine Tighiouart, Alfred K K Cheung, Andrew S S Levey, Garabed Eknoyan, Dana C C Miskulin
    posted to ca hd p rct by jyuh on 2008-08-06 07:36:13 as **
  • Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
    N Engl J Med (30 March 2008), NEJMoa0800742.
    by John J Kastelein, Fatima Akdim, Erik S Stroes, Aeilko H Zwinderman, Michiel L Bots, Anton F Stalenhoef, Frank L Visseren, Eric J Sijbrands, Mieke D Trip, Evan A Stein, Daniel Gaudet, Raphael Duivenvoorden, Enrico P Veltri, David A Marais, Eric de Groot, The E Investigators
    posted to ldl lipid rct statin by jyuh on 2008-08-06 04:47:46 as ** along with 3 people A_Hoogendam omalbam rdragu
  • A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
    Contemporary clinical trials, Vol. 27, No. 5. (October 2006), pp. 483-491.
    by L Nie, H Chu, SR Cole
    posted to lod power rct by jyuh on 2008-07-29 10:09:25 as **
  • Lack of generalizability of sensitivity and specificity with treatment effects.
    Statistics in medicine, Vol. 27, No. 10. (10 May 2008), pp. 1734-1744.
    by LE Dodd, EL Korn
    posted to diagnosis laboratory rct by jyuh on 2008-07-29 05:34:45 as **
  • Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.
    Drug and alcohol dependence, Vol. 95 Suppl 1 (1 June 2008)
    by CH Brown, W Wang, SG Kellam, BO Muthén, H Petras, P Toyinbo, J Poduska, N Ialongo, PA Wyman, P Chamberlain, Z Sloboda, DP MacKinnon, A Windham,
    posted to rct by jyuh on 2008-07-29 03:51:10 as **
  • The effectiveness of a primer to help people understand risk: two randomized trials in distinct populations.
    Ann Intern Med, Vol. 146, No. 4. (20 February 2007), pp. 256-265.
    by S Woloshin, LM Schwartz, HG Welch
    posted to rct risk by jyuh on 2008-07-29 03:47:35 as ** along with 1 person lauras
  • Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS
    Computational Statistics & Data Analysis, Vol. 51, No. 9. (15 May 2007), pp. 4152-4163.
    by Abel Tilahun, Assam Pryseley, Ariel Alonso, Geert Molenberghs
    posted to r rct sas software surrogate by jyuh on 2008-07-28 14:39:26 as **
  • Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpoints.
    Clinical trials (London, England), Vol. 4, No. 6. (2007), pp. 587-597.
    by A Pryseley, A Tilahun, A Alonso, G Molenberghs
    posted to r rct software surrogate by jyuh on 2008-07-28 14:04:58 as **
  • A New Nonparametric Approach for Baseline Covariate Adjustment for Two-Group Comparative Studies.
    Biometrics (2008)
    by A Schacht, K Bogaerts, E Bluhmki, E Lesaffre
    posted to ancova nonparametric rct software by jyuh on 2008-07-28 10:52:59 as **
  • A New Nonparametric Approach for Baseline Covariate Adjustment for Two-Group Comparative Studies.
    Biometrics (11 February 2008)
    by Alexander Schacht, Kris Bogaerts, Erich Bluhmki, Emmanuel Lesaffre
    posted to ancova nonparametric rct software by jyuh on 2008-07-28 10:48:03 as **
  • Statistical challenges in the evaluation of surrogate endpoints in randomized trials.
    Controlled clinical trials, Vol. 23, No. 6. (December 2002), pp. 607-625.
    by G Molenberghs, M Buyse, H Geys, D Renard, T Burzykowski, A Alonso
    posted to rct surrogate by jyuh on 2008-07-28 05:18:30 as **
  • Statistical challenges in the evaluation of surrogate endpoints in randomized trials
    Controlled Clinical Trials, Vol. 23, No. 6. (December 2002), pp. 607-625.
    by Geert Molenberghs, Marc Buyse, Helena Geys, Didier Renard, Tomasz Burzykowski, Ariel Alonso
    posted to rct surrogate by jyuh on 2008-07-28 04:39:37 as **
  • Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data
    Biometrics, Vol. 64, No. 1. (March 2008), pp. 149-156.
    by Ghosh, Debashis
    posted to rct surrogate by jyuh on 2008-07-28 04:38:18 as **
  • On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?
    Statistics in medicine, Vol. 26, No. 5. (28 February 2007), pp. 954-964.
    by H Bang, CE Davis
    posted to compliance intrumental-variable rct by jyuh on 2008-07-27 10:57:30 as **
  • Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.
    JAMA : the journal of the American Medical Association, Vol. 297, No. 6. (14 February 2007), pp. 603-610.
    by LR Zacharski, BK Chow, PS Howes, G Shamayeva, JA Baron, RL Dalman, DJ Malenka, CK Ozaki, PW Lavori
    posted to cv iron rct by jyuh on 2008-07-27 05:59:28 as **
  • Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study).
    Circulation, Vol. 117, No. 4. (29 January 2008), pp. 494-502.
    by K Mizuno, N Nakaya, Y Ohashi, N Tajima, T Kushiro, T Teramoto, S Uchiyama, H Nakamura,
    posted to gender japan rct statin by jyuh on 2008-07-26 00:36:22 as **
  • Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.
    Lancet, Vol. 368, No. 9542. (30 September 2006), pp. 1155-1163.
    by H Nakamura, K Arakawa, H Itakura, A Kitabatake, Y Goto, T Toyota, N Nakaya, S Nishimoto, M Muranaka, A Yamamoto, K Mizuno, Y Ohashi,
    posted to cad japan rct statin by jyuh on 2008-07-26 00:36:03 as **
  • Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
    The Lancet, Vol. 362, No. 9395. (8 November 2003), pp. 1527-1535.
    posted to bp cv meta-analysis rct by jyuh on 2008-07-21 05:40:02 as **
  • Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    The American journal of cardiology, Vol. 100, No. 3A. (6 August 2007)
    by M Böhm
    posted to acei arb cv dual rct by jyuh on 2008-07-21 05:03:00 as **
  • The COOPERATE trial: a letter of concern.
    Lancet, Vol. 371, No. 9624. (10 May 2008), pp. 1575-1576.
    by R Kunz, M Wolbers, T Glass, JF Mann
    posted to acei arb meta-analysis rct by jyuh on 2008-07-21 05:00:41 as **
  • Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.
    Lancet, Vol. 361, No. 9352. (11 January 2003), pp. 117-124.
    by N Nakao, A Yoshimura, H Morita, M Takada, T Kayano, T Ideura
    posted to acei arb ckd dual rct by jyuh on 2008-07-21 04:47:08 as **
  • Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) and resource utilization and costs in Italy.
    Vascular health and risk management, Vol. 4, No. 1. (2008), pp. 223-234.
    by GL Colombo, M Caruggi, C Ottolini, AP Maggioni
    posted to acei arb cost-effective dual rct by jyuh on 2008-07-21 04:19:24 as **
  • Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 149-156.
    by JJ McMurray, PE Carson, M Komajda, R McKelvie, MR Zile, A Ptaszynska, C Staiger, JM Donovan, BM Massie
    posted to chf diastolic rct by jyuh on 2008-07-21 04:11:39 as **
  • Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
    European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163.
    by RA Weir, JJ McMurray, M Puu, SD Solomon, B Olofsson, CB Granger, S Yusuf, EL Michelson, K Swedberg, MA Pfeffer,
    posted to acei arb chf dual rct by jyuh on 2008-07-21 04:10:12 as **
  • Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Circulation, Vol. 115, No. 24. (19 June 2007), pp. 3111-3120.
    by E O'Meara, T Clayton, MB McEntegart, JJ McMurray, IL Piña, CB Granger, J Ostergren, EL Michelson, SD Solomon, S Pocock, S Yusuf, K Swedberg, MA Pfeffer,
    posted to arb chf gender rct by jyuh on 2008-07-21 04:09:11 as **
  • Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
    The Lancet, Vol. 372, No. 9634., pp. 224-233.
    by Matthew J Mcqueen, Steven Hawken, Xingyu Wang, Stephanie Ounpuu, Allan Sniderman, Jeffrey Probstfield, Krisela Steyn, John E Sanderson, Mohammad Hasani, Emilia Volkova, Khawar Kazmi, Salim Yusuf
    posted to cad lipid rct by jyuh on 2008-07-21 03:57:06 as **
  • Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
    Lancet, Vol. 362, No. 9395. (8 November 2003), pp. 1527-1535.
    by F Turnbull,
    posted to bp cv rct by jyuh on 2008-07-21 02:08:46 as **
  • Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy.
    The Canadian journal of cardiology, Vol. 24, No. 6. (June 2008), pp. 491-496.
    by DM Rabi, N Khan, M Vallee, MA Hladunewich, SW Tobe, L Pilote
    posted to acei arb gender rct by jyuh on 2008-07-20 15:56:27 as **
  • Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease. A Randomized Double-Blind Pilot Trial.
    Hypertension (7 July 2008)
    by Pooneh Alborzi, Nina A A Patel, Carla Peterson, Jennifer E E Bills, Dagim M M Bekele, Zerihun Bunaye, Robert P P Light, Rajiv Agarwal
    posted to ckd inflammation rct vitamin-d by jyuh on 2008-07-20 11:46:56 as **
  • Irbesartan : a review of its use in hypertension and diabetic nephropathy.
    Drugs, Vol. 68, No. 11. (2008), pp. 1543-1569.
    by KF Croom, GL Plosker
    posted to arb dn rct by jyuh on 2008-07-19 16:47:50 as **
  • Bayesian interim analysis in clinical trials.
    Contemporary clinical trials (4 June 2008)
    by Xiao Zhang, Gary Cutter
    posted to bayes rct by jyuh on 2008-07-15 05:44:24 as **
  • Graphical approaches to the analysis of safety data from clinical trials.
    Pharmaceutical statistics, Vol. 7, No. 1. (r 2008), pp. 20-35.
    by O Amit, RM Heiberger, PW Lane
    posted to rct by jyuh on 2008-07-11 11:43:28 as ** along with 1 person cucherat
  • Sample size calculations in randomized trials: common pitfalls.
    Canadian journal of anaesthesia = Journal canadien d'anesthésie, Vol. 54, No. 2. (February 2007), pp. 103-106.
    by PM Brasher, RF Brant
    posted to power rct by jyuh on 2008-07-11 05:01:51 as **
  • Disciplined analyses in clinical trials: the dark heart of the matter.
    Statistical methods in medical research, Vol. 17, No. 3. (June 2008), pp. 253-264.
    by LA Moyé
    posted to rct statistics by jyuh on 2008-07-11 04:28:11 as **
  • A note on tree gatekeeping procedures in clinical trials.
    Statistics in medicine, Vol. 27, No. 17. (30 July 2008), pp. 3446-3451.
    by A Dmitrienko, AC Tamhane, L Liu, BL Wiens
    posted to rct by jyuh on 2008-07-11 03:55:46 as **
  • Sample size and the probability of a successful trial.
    Pharmaceutical statistics, Vol. 5, No. 4. (c 2006), pp. 305-309.
    by C Chuang-Stein
    posted to futility power rct by jyuh on 2008-07-11 03:37:13 as **
  • Assessment of futility in clinical trials.
    Pharmaceutical statistics, Vol. 5, No. 4. (c 2006), pp. 273-281.
    by S Snapinn, MG Chen, Q Jiang, T Koutsoukos
    posted to futility rct by jyuh on 2008-07-11 03:36:41 as ** along with 1 person alanjin
  • An overview of statistical approaches for adaptive designs and design modifications.
    Biometrical journal. Biometrische Zeitschrift, Vol. 48, No. 4. (August 2006), pp. 507-520.
    by H Schäfer, N Timmesfeld, HH Müller
    posted to rct by jyuh on 2008-07-11 03:34:39 as **
  • Successful treatment of hypoalbuminemic hemodialysis patients with a modified regimen of oral essential amino acids
    Journal of Renal Nutrition, Vol. 11, No. 4. (October 2001), pp. 194-201.
    by Lauren Bronich, Tite Te, Kedar Shetye, Tara Stewart, Joseph A Eustace
    posted to albumin idn rct by jyuh on 2008-07-08 10:23:22 as **
  • Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial.
    Critical care medicine, Vol. 36, No. 1. (January 2008), pp. 131-144.
    by RJ Beale, T Sherry, K Lei, L Campbell-Stephen, J McCook, J Smith, W Venetz, B Alteheld, P Stehle, H Schneider
    posted to icu nutrition rct by jyuh on 2008-07-08 09:29:21 as **
  • Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study.
    Critical care medicine, Vol. 34, No. 10. (October 2006), pp. 2536-2540.
    by MJ Dubois, C Orellana-Jimenez, C Melot, D De Backer, J Berre, M Leeman, S Brimioulle, O Appoloni, J Creteur, JL Vincent
    posted to albumin icu rct by jyuh on 2008-07-08 09:28:58 as **
  • Surrogate markers, atherosclerosis and cardiovascular disease prevention
    International Journal of Clinical Practice, Vol. 62, No. 7. (July 2008), pp. 981-987.
    by Wierzbicki,
    posted to cv rct surrogate by jyuh on 2008-07-08 08:00:53 as **
  • On reporting results from randomized controlled trials with recurrent events
    BMC Medical Research Methodology, Vol. 8 (30 May 2008), 35.
    by Lisa K Kuramoto, Boris G Sobolev, Meghan G Donaldson
    posted to rct recurrent by jyuh on 2008-07-08 07:44:44 as **
    • Du kan hänvisa till den här sidan som: http://www.citeulike.org/user/jyuh/tag/rct

    Result page: 1 2 3 4 5 6 7 8 9 Next RIS BibTeX